← Open Payments lookup

ADAM KARNS: Open Payments

NPI 1811979198 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,292 in 139 payments from 27 companies in 2025. Trend: 2023 $5,029 · 2024 $4,095 · 2025 $10,292

Consulting: $5,222Food & beverage: $4,382Travel & lodging: $687
CompanyPaymentsAmount
Astellas Pharma US Inc12$6,097
Neurocrine BioSciences, Inc.24$910
AstraZeneca Pharmaceuticals LP17$479
Amgen Inc.5$352
Axsome Therapeutics, Inc.18$335
ABBVIE INC.9$277
Gilead Sciences, Inc.4$220
Bayer Healthcare Pharmaceuticals Inc.4$209
Boehringer Ingelheim Pharmaceuticals, Inc.5$180
BridgeBio Pharma, Inc.1$167

Products named: Veozah, INGREZZA, Auvelity, BREZTRI, Kerendia, VRAYLAR, REPATHA, Attruby.

Industry payments across CA — which companies pay providers there.